| Dr Orlando J Penaloza, MD | |
|
17th And Chew Streets, Suite 403, Allentown, PA 18104 | |
| (610) 969-3600 | |
| Not Available |
| Full Name | Dr Orlando J Penaloza |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 32 Years |
| Location | 17th And Chew Streets, Allentown, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083881585 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | MD440584 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lehigh Valley Hospital | Allentown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Valley Health Partners Community Health Center | 4284065327 | 59 |
News Archive
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Last week, the UK health secretary declared that we are in a grip of an obesity epidemic, but does the evidence stack up? Researchers in this week's BMJ debate the issue.
Today at the annual RAPS (Regulatory Affairs Professionals Society) conference in booth #607, Prolifiq announced software that allows Life Sciences companies to comply with an increasingly complex web of regulations governing sales communication. Prolifiq for Life Sciences-designed for medical device, pharmaceutical and biotechnology companies-is used to organize, send and track approved digital content to health care practitioners.
News outlets report on implementation issues including the declining rate of uninsured people, confusion created by recent administrative changes and a union's assertion that the law will increase inequality.
› Verified 7 days ago
| Entity Name | Lehigh Valley Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457309650 PECOS PAC ID: 3072425123 Enrollment ID: O20040227000335 |
News Archive
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Last week, the UK health secretary declared that we are in a grip of an obesity epidemic, but does the evidence stack up? Researchers in this week's BMJ debate the issue.
Today at the annual RAPS (Regulatory Affairs Professionals Society) conference in booth #607, Prolifiq announced software that allows Life Sciences companies to comply with an increasingly complex web of regulations governing sales communication. Prolifiq for Life Sciences-designed for medical device, pharmaceutical and biotechnology companies-is used to organize, send and track approved digital content to health care practitioners.
News outlets report on implementation issues including the declining rate of uninsured people, confusion created by recent administrative changes and a union's assertion that the law will increase inequality.
› Verified 7 days ago
| Entity Name | Valley Health Partners Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770118648 PECOS PAC ID: 4284065327 Enrollment ID: O20200505003199 |
News Archive
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Last week, the UK health secretary declared that we are in a grip of an obesity epidemic, but does the evidence stack up? Researchers in this week's BMJ debate the issue.
Today at the annual RAPS (Regulatory Affairs Professionals Society) conference in booth #607, Prolifiq announced software that allows Life Sciences companies to comply with an increasingly complex web of regulations governing sales communication. Prolifiq for Life Sciences-designed for medical device, pharmaceutical and biotechnology companies-is used to organize, send and track approved digital content to health care practitioners.
News outlets report on implementation issues including the declining rate of uninsured people, confusion created by recent administrative changes and a union's assertion that the law will increase inequality.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Orlando J Penaloza, MD Po Box 783311, Philadelphia, PA 19178-3311 Ph: () - | Dr Orlando J Penaloza, MD 17th And Chew Streets, Suite 403, Allentown, PA 18104 Ph: (610) 969-3600 |
News Archive
In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.
Last week, the UK health secretary declared that we are in a grip of an obesity epidemic, but does the evidence stack up? Researchers in this week's BMJ debate the issue.
Today at the annual RAPS (Regulatory Affairs Professionals Society) conference in booth #607, Prolifiq announced software that allows Life Sciences companies to comply with an increasingly complex web of regulations governing sales communication. Prolifiq for Life Sciences-designed for medical device, pharmaceutical and biotechnology companies-is used to organize, send and track approved digital content to health care practitioners.
News outlets report on implementation issues including the declining rate of uninsured people, confusion created by recent administrative changes and a union's assertion that the law will increase inequality.
› Verified 7 days ago
Jessica Mary Boehmler, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 205, Allentown, PA 18103 Phone: 610-439-8856 Fax: 610-439-8856 | |
Allison Jane Baragona, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1501 N Cedar Crest Blvd Ste 110, Allentown, PA 18104 Phone: 610-821-2828 Fax: 610-821-7915 | |
James A Burke, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1250 S Cedar Crest Blvd, Suite 300, Allentown, PA 18103 Phone: 610-402-3110 Fax: 610-402-3112 | |
Stephen R Shore, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1901 Hamilton St Ste 300, Allentown, PA 18104 Phone: 610-628-7900 Fax: 833-816-7513 | |
Tarika Sejal Chowdhary, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 17th & Chew, Suite 101, Allentown, PA 18105 Phone: 610-969-4370 | |
Ashley Vojtek, DO Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 1200 S Cedar Crest Blvd, Allentown, PA 18103 Phone: 484-862-3200 | |
Dr. Ian William Klansek, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 2490 Schoenersville Rd, Allentown, PA 18109 Phone: 484-526-7262 |